The Daily Byte
Breaking
Welcome to The Daily Byte — real stories from across Pakistan.
Saturday, 21 November 2026 · Pakistan

The Daily Byte

Stories from Pakistan that deserve to be heard
Minor Markets

UnitedHealth, Humana Rebound After Brutal Week

By The Daily Byte ·21 Nov 2026 ·4 min read
UnitedHealth Group headquarters building in Minnetonka with company name on facade

UnitedHealth and Humana shares bounced back on Friday after a brutal week for American health insurers, as a leading Wall Street broker upgraded both stocks and named UnitedHealth one of its top picks for 2027.

UnitedHealth Group rose 4.7% to $346.08, while Humana gained 5.4% to $400.71, with both stocks among the best performers in the S&P 500 on Friday, according to Barron's. The rebound came after TD Cowen analyst Ryan Langston upgraded both insurers to Buy from Hold.

Langston named UnitedHealth a top pick for 2027 and raised his price target on the stock to $455 from $402. He raised his target on Humana to $485 from $430. He estimated that UnitedHealth's profits could grow roughly 15% to 19% a year through at least 2028, driven by smarter pricing in its Medicare Advantage business, a continuing recovery at its Optum Health unit, and a rebound from weak profit margins in commercial and Medicaid insurance.

For Humana, Langston projected that profits will more than quadruple by 2028 and beat Wall Street's estimates. He pointed to the company's decision to raise out-of-pocket limits and trim perks on its 2027 Medicare plans, lifting profit margins without losing customers.

A week investors will want to forget

Even with Friday's bounce, both stocks were heading for their worst weekly performance since the week ended 30 January, according to Dow Jones Market Data. UnitedHealth has tumbled about 15% this week and Humana about 12%.

The sell-off began on Monday, when the federal Centers for Medicare and Medicaid Services proposed a new rule, called CRUSH, to expand audits of Medicare Advantage plans, the privately run version of the US government's health programme for older Americans. Under the proposal, findings from a sample of medical records would be extrapolated to a plan's whole contract, reaching back to payment year 2018, and the agency estimates the expanded audits could recover roughly $90 billion over ten years.

The rule targets "upcoding", the practice of recording patients as sicker than they are so insurers can receive bigger payments from Medicare. Raymond James analyst Chris Meekins called the proposal "a potentially significant expansion of federal oversight across federally funded health programs".

The selling deepened on Wednesday, when UnitedHealth closed 10.2% lower at $349.91 and Humana fell 13% to $385.78, while CVS Health, which owns Aetna, dropped 5.2% to $81.35. UnitedHealth fell a further 5.6% on Thursday, taking its drop over five days to 19%. Humana has tumbled 15.8% over the same period and CVS is down 10.9%.

Investors were also rattled by a second scare from Washington. Senator Bernie Sanders said he would push a Medicare for All proposal, aiming to gradually lower the age of eligibility for Medicare coverage over four years as part of his agenda on the Senate health committee.

Why some analysts see a buying opportunity

Not everyone on Wall Street is worried. Mizuho analyst Ann Hynes noted that nobody knows yet how much money will actually be clawed back under the audit rule, or how long court fights will delay it. Humana previously sued over a similar audit rule from 2023, which a federal judge in Texas threw out in September 2025; the government has appealed.

Hynes also pointed to history: the same panic hit insurance stocks in 2019 during the last big Medicare for All debate, and the shares bounced back as soon as investors concluded the bill would not pass. "We believe the recent sell-off is pricing in a significant amount of policy risk and reiterate our Outperform ratings across our managed care coverage," she wrote.

Analysts remain broadly bullish on both insurers.

Frequently asked questions

What is the CRUSH rule?

CRUSH stands for Comprehensive Regulations to Uncover Suspicious Healthcare. It is a proposed rule from the Centers for Medicare and Medicaid Services that would widen audits of Medicare Advantage plans and let the government extrapolate audit findings across whole contracts, back to payment year 2018.

Why did UnitedHealth and Humana shares rise on Friday?

TD Cowen upgraded both stocks to Buy from Hold, named UnitedHealth a top pick for 2027, and raised its price targets, arguing the sell-off had gone too far given the insurers' profit outlook.

What is Medicare Advantage?

Medicare Advantage is the privately run version of Medicare, the US government health programme for people aged 65 and over. Private insurers such as UnitedHealth, Humana and CVS's Aetna operate the plans and are paid by the government to cover members.

Source: Barron's
Source: MarketWatch